Guru Ownership Trend
Guru Analysis for Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $172.24 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $16.34 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 500.3%. Conversely, Paul Tudor Jones reduced exposure by 82.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Travere Therapeutics, Inc. (TVTX)
Major holders include Renaissance Technologies (RenTech) ($104.14 M), Steven Cohen ($27.2 M), Cliff Asness ($15.34 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.66 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.34 M, with 2 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 0 fully exited TVTX. The total reported sell value was $12.23 M.
Yes, 1 managers opened new positions in TVTX, and 1 increased their existing holdings. The total reported buy value was $28.58 M.
